Skip to main content
OpenTrials
Completed

NCT Number: NCT01781416

Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk

This is a national, non interventional, prospective study performed in the general practice setting.

The study has been designed :

* to assess the level of concordance between patients' cardiovascular risk perception and the cardiovascular risk evaluated by the physicians, * and to evaluate the impact of patients' exposure to a medical information leaflet on patients' cardiovascular risk perception.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site

Paris, France

About this study

LEVEL OF CONCORDANCE BETWEEN PATIENTS PERCEPTION AND PHYSICIANS EVALUATION OF CARDIOVASCULAR RISK

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Currently in primary prevention for a cardiovascular event (patient with no known history of acute cardiovascular or cerebrovascular event)
  • Usually treated by the GP
  • Having signed the information and consent form

Exclusion criteria

  • Patient with a pathologic vascular ultrasound exam (atheromatous plaque or stenosis)
  • Patient unable to read and complete the study documentation

Treatment and study plan

Primary outcomes

  1. Cardiovascular risk perceived by patients (before reading the Medical Information Leaflet)

    Time frame: Baseline

  2. Cardiovascular risk assessed by physicians

    Time frame: Baseline

Secondary outcomes

  1. Cardiovascular risks perceived by patients before and after reading the Medical Information Leaflet

    Time frame: Baseline

  2. Actual cardiovascular risk calculated using SCORE

    Time frame: Baseline

  3. Characteristics of patients whose self-evaluation of their CVR is concordant with their actual CVR

    Time frame: Baseline

  4. Characteristics of patients whose self-evaluation of their CVR is discordant with their actual CVR

    Time frame: Baseline

  5. Risk factors considered by patients in self-assessing their CVR

    Time frame: Baseline

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: PERCEPTION

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Feb 1, 2013
Registry last updated
May 20, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.